DuPont invests $10 million to upgrade Wisconsin probiotic facility

DuPont invests $10 million to upgrade Wisconsin probiotic facility

DuPont Nutrition & Health upgraded its probiotics pilot facility in Madison, WI, a project that costs around $10 million and aims to increase pace of new product development.

“Given the explosive rise in demand for probiotics products all around the globe, this project allows us to aggressively pursue our goal to be the No. 1 probiotics supplier in the world,” said DuPont Nutrition & Health President Matthias Heinzel. Euromonitor estimated the global probiotic market’s value at €40bn in 2016, or US$47 billion.

“These expansion efforts show our commitment to becoming bigger and stronger with our capability to meet demand, and our facilities, and qualified staff to handle the significant growth we foresee in this sector.”

Construction on the pilot area, which was completed over the last six months, will help the company improve overall scale-up capability and a more seamless transition to commercial scale production.

Though square footage was not disclosed, the company said that these upgrades “quadrupled the pilot area.” It will add state-of-the-art equipment, data collection, laboratories, instrumentation, and specialized work space for probiotic development and scale up.

“With all the enhancements, we are better able to meet customer demand for new probiotics at a much faster pace,” said Kurt Fenster, BioProcess Development group manager, Culture Manufacturing Technology at DuPont Nutrition & Health. “Moving forward, we expect to substantially increase our speed to deliver products to customers.”

Expanding its Midwestern facility in Wisconsin was part of a bigger effort for the giant ingredient supplier to push further into the probiotics space.

Back in 2016, DuPont announced that it would expand its US probiotics production capacity through a $100 million, multiphase plan. Earlier this summer, the company expanded its operations in Rochester, NY, creating 48 new jobs.

Related News

Is pharma interest in probiotics a challenge or opportunity?

Is pharma interest in probiotics a challenge or opportunity?

© iStock

What is a probiotic? IPA releases guidance document on qualifying probiotics

DuPont: There's opportunity in new probiotic enumeration technology

There's opportunity in new probiotic enumeration technology, says expert

Summer Product Launches: Probiotic shots, lucid dreaming capsules, and more

Summer Product Launches: Probiotic shots, lucid dreaming capsules, and more

© iStock

Deerland Enzymes & Probiotics earns Non-GMO Project verification for 2 ingredients

Garden of Life earns Non-GMO Project verification for probiotics line

Garden of Life earns Non-GMO Project verification for probiotics line

August New Product Launches: Chewable probiotics, pumpkin seed protein, and green juice

August New Product Launches: Chewable probiotics, pumpkin seed protein, and green juice

Jarrow challenges FDA on probiotics

Jarrow challenges FDA on probiotics

Ganeden bets on inactivated probiotic ingredient for new applications

Ganeden bets on inactivated probiotic ingredient for new applications

Yakult is ready to begin carrying out tests on the consumption of probiotics in space. ©iStock

Probiotics in space testing is ready for lift off, says Yakult

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.